middle.news
Cleo Diagnostics Clarifies Share Surge Amid Ovarian Cancer Tech Progress
5:58pm on Friday 7th of February, 2025 AEDT
•
Healthcare
Read Story
Cleo Diagnostics Clarifies Share Surge Amid Ovarian Cancer Tech Progress
5:58pm on Friday 7th of February, 2025 AEDT
Key Points
Share price rose from $0.35 to $0.44 with increased trading volume
No undisclosed material information explaining price movement
Patented ovarian cancer detection technology with 95% sensitivity and specificity
Ongoing U.S. clinical trials aiming for FDA submission in 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cleo Diagnostics (ASX:COV)
OPEN ARTICLE